Developing and Using Analytical Methods to Achieve Quality by Design and Efficiency in Drug Development

The author describes strategies for analytical method development that are helpful in achieving quality by design and efficiency.

External Link - article-150849.pdf

Articles in this issue

over 21 years ago

Article

How to Scale Up Scientifically

over 21 years ago

Article

Scale Up of Liquid and Semisolid Manufacturing Processes

over 21 years ago

Article

Scale Up of Powder-Blending Operations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

FDA-approved RASONQUE (daraxonrasib) tablets mark the first broad RAS-targeted therapy for metastatic pancreatic cancer treatment.

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

ByZachary Zubulake

August 26th 2026

Data-driven pharma development: analytics and predictive modelling are reshaping how drug development risks are identified and managed.

Can Predictive Modelling Fix Fragmented Pharma Development Data?

ByZachary Zubulake

August 26th 2026

Breakdown process of medicine in lukewarm water | Image Credit: ©taffpixture -stock.adobe.com

Rethinking the Path from Spray-Dried Dispersions to Tablets: The Role of Continuous Direct Compression

ByAnthony Tantuccio

August 26th 2026

3D bioprinting is the utilization of 3D printing to combine cells, growth biomaterials to make biomedical parts | Image Credit: ©luchschenF -stock.adobe.com

3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe

ByCheryl Barton

August 26th 2026

The implications of the FDA’s acceptance for GSK’s dostarlimab for a priority review a supplemental application

GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift

ByZachary Zubulake

August 25th 2026

Developing and Using Analytical Methods to Achieve Quality by Design and Efficiency in Drug Development

Articles in this issue

Related Content

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

Can Predictive Modelling Fix Fragmented Pharma Development Data?

Rethinking the Path from Spray-Dried Dispersions to Tablets: The Role of Continuous Direct Compression

3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe

GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift

Trending on Pharmaceutical Technology

What the McKesson-Precision Medicine Deal Signals for Trial Sponsors

GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift

From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk

3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe

Rethinking the Path from Spray-Dried Dispersions to Tablets: The Role of Continuous Direct Compression